Consultation: Amending the Food and Drug Regulations to provide expedited access to COVID-19 drugs

From: Health Canada

Current status: Open

Opened on November 30th, 2020, and closed on December 21st, 2020.

The Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 introduced new regulatory pathways to expedite the authorization of COVID-19 drugs to meet a public health emergency without compromising patient safety. The interim order (IO) expires on September 16, 2021. To ensure uninterrupted access to these drugs, Health Canada is proposing to amend the Food and Drug Regulations.

Join in: how to participate

Review the proposal

Consultation on amending the Food and Drug Regulations to expedite access to COVID-19 drugs

Send us an email

hc.hpfb-covid19-dgpsa.sc@canada.ca

Who is the focus of this consultation

The Government of Canada will engage with:

Key questions for discussion

Industry plays an important role in facilitating early access to these drugs. Through this consultation, Health Canada wants to make sure key stakeholders:

Your ideas and input are sought:

The input gathered through this process will help Health Canada’s work on amending the Food and Drug Regulations to ensure that Canadians continue to have access to COVID-19 drugs.

Contact us

Contact us by email: hc.hpfb-covid19-dgpsa.sc@canada.ca

Related links

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: